Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-12-08

Clinical Trial Update: Fycompa Titration Intervals and Effects on Retention Rate [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating Fycompa (perampanel) titration intervals and their impact on retention rate in epilepsy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fycompa (perampanel)

Snippet

Sponsor: University of Arizona | Conditions: Epilepsy | Phase 4 | Status: COMPLETED | Results posted: 2021-12-08